For the Inventor, By the Inventor

Enter inventor name

Gif-sur-Yvette, France

Jeremiah Harnett

USPTO Granted Patents = 29 (Patent Applications = 5)

CIPO Patents = 3

EPO Patents = 5 (Patent Applications = 7)

Average Co-Inventor Count = 4.0

ph-index = 8

Forward Citations = 204(Granted Patents)

Company Filing History:

Societe De Conseils De Recherches Et D'applications Scientifiques (s.c.r.a.s.)

Ipsen Pharma S.a.s.

Britannia Pharmaceuticals Limited

Societe De Conseils De Recherches Et D'applications Scientifiques

Societe De Conseils De Recherches Et D'applications (s.c.r.a.s.)

7. 1 out of 832,912

Other

patents

Years Active: 2002-2023

Loading Chart...

Loading Chart...

Loading Chart...

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11766431 - Therapeutical composition containing apomorphine as active ingredient (2023-09-26),

2. 11026938 - Therapeutical composition containing apomorphine as active ingredient (2021-06-08),

3. 9511023 - Clay compositions (2016-12-06),

4. 9415012 - Sustained-release composition containing peptides as active ingredient (2016-08-16),

5. 8288560 - Derivatives of heterocycles with 5 members, their preparation and their use as medicaments (2012-10-16),

6. 7956075 - Derivatives of heterocycles with 5 members, their preparation and their use as medicaments (2011-06-07),

7. 7576241 - Derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them (2009-08-18),

8. 7553976 - Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them (2009-06-30),

9. 7473779 - Derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them (2009-01-06),

10. 7459558 - Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them (2008-12-02),

11. 7345066 - Use of thiazole derivatives for preparing a medicine for protecting mitochondria (2008-03-18),

12. 7285664 - Heterocyclic or benzenic derivatives of lipoic acid, their preparation and their use as medicaments (2007-10-23),

13. 7186752 - Derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them (2007-03-06),

14. 7122535 - Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them (2006-10-17),

15. 7019025 - Derivatives of amidines, their preparation and their use as medicaments (2006-03-28),

Title: **Jeremiah Harnett: Innovator in Pharmaceutical Composition**

Introduction

Jeremiah Harnett is a highly regarded inventor based in Gif-sur-Yvette, France. With an impressive portfolio of 29 patents, he has made significant contributions to the field of pharmaceutical sciences. His work primarily focuses on therapeutic compositions that aim to improve the treatment of various medical conditions, including Parkinson's disease.

Latest Patents

Among his latest innovations is a therapeutic composition containing apomorphine as the active pharmaceutical ingredient. This formulation incorporates a water-miscible co-solvent, an antioxidant, and water, creating a solution with a pH greater than 4. The composition is specifically designed for parenteral administration, making it suitable for the treatment of Parkinson's disease. The manufacturing process for this pharmaceutical composition involves weighing the apomorphine and introducing it into a container with the co-solvent and antioxidant under agitation until complete dissolution occurs.

Career Highlights

Jeremiah has had a notable career, contributing his expertise at several esteemed organizations. He has worked for Société de Conseils de Recherches et d'Applications Scientifiques (SCRAS) and Ipsen Pharma S.A.S., where he has further advanced pharmaceutical research and development.

Collaborations

Throughout his career, Jeremiah has collaborated with distinguished professionals in the field. Notable coworkers include Serge Auvin and Dennis Bigg, both of whom have contributed to the advancement of pharmaceutical innovations alongside him.

Conclusion

Jeremiah Harnett's work exemplifies the spirit of innovation in pharmaceuticals. With his extensive patent portfolio and impactful collaborations, he continues to pave the way for advancements that enhance therapeutic options for patients with Parkinson's disease and beyond. His contributions to the field of medicine highlight the importance of innovative thinking and dedicated research in developing effective treatments.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…